These investigators revealed that anti-TNF therapy combined with immunomodulatory therapy (azathioprine, 6-mercaptopurine, or methotrexate) reduced both disease activity and symptoms of anxiety/depression in patients with IBD. The gene discussed is TNF; the disease is major depressive disorder.